The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Nanomedicines for Reactive Oxygen Species Mediated Approach: An Emerging Paradigm for Cancer Treatment
Abstract
Conspectus Growth in the knowledge of cancer biology has led to the emergence and evolution of cancer nanomedicines by providing the rationale for leveraging nanotechnology to develop better treatment options. The discovery of nanometer-sized intercellular openings in the defective angiogenic tumor vasculature contributed to the development of an idea for the well-known cancer passive targeting regime, enhanced permeability and retention (EPR) effect, of the nanomedicines. Recently, reactive oxygen species (ROS) have been highlighted as one of the key players that underlie the acquisition of the various hallmarks of cancer. As ROS are associated with all stages of cancer, their applications in cancer treatment based on the following concentration-dependent implications have attracted much attention: (1) low to moderate levels of ROS as key signaling molecules, (2) elevated levels of ROS in cancer cells as one of the unique characteristics of cancer, and (3) excessive levels of ROS as cytotoxic agents. Considering ROS from a different point of view, various cancer nanomedicines have been designed to achieve spatiotemporal control of therapeutic action, the main research focus in this area. This Account includes our efforts and preclinical achievements in development of nanomedicines for a range of ROS-mediated cancer therapies. It begins with general background regarding cancer nanomedicines, the significance of ROS in cancer, and a brief overview of ROS-mediated approaches for cancer therapy. Then, this Account highlights the two key roles of ROS that define therapeutic purposes of cancer nanomedicines: (1) ROS as drug delivery enhancers and (2) ROS as cell death inducers. The former inspired us to develop nitric oxide-generating nanoparticles for improved EPR effect, endogenous ROS-responsive polymeric micelles for enhanced intracellular drug delivery, and exogenous ROS-activated micelles for subcellular localization via photochemical internalization. While refining conventional chemotherapy, recent researches also have focused on the latter, the cytotoxic ROS, to advance alternative treatment modalities such as oxidation therapy, photodynamic therapy (PDT), and sonodynamic therapy (SDT). In particular, we have been motivated to develop polymeric nanoreactors containing enzymes to produce H 2 O 2 for oxidation therapy, photosensitizer-loaded gold-nanoclustered polymeric nanoassemblies for photothermally activated PDT overcoming the oxygen dependency of PDT, and hydrophilized TiO 2 nanoparticles and Au-TiO 2 nanocomposites as novel sonosensitizers for improved SDT efficiency. The integration of nanomedicine and ROS-mediated therapy has emerged as the new paradigm in the treatment of cancer, based on promising proof-of-concept demonstrations in preclinical studies. Further efforts to ensure clinical translation along with more sophisticated cancer nanomedicines to address relevant challenges are expected to be made in the coming years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Cancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Trachootham, D., Alexandre, J., & Huang, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2803 · Cited by 5,452
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744
ROS as signalling molecules: Mechanisms that generate specificity in ROS homeostasis
D'Autréaux, B., & Toledano, M. B. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2256 · Cited by 3,642
Modulation of oxidative stress as an anticancer strategy
Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579
Nanoparticles in Photodynamic Therapy
Lucky, S. S., Soo, K. C., & Zhang, Y. (2015) · Chemical Reviews · doi:10.1021/cr5004198 · Cited by 2,980
Progress and challenges towards targeted delivery of cancer therapeutics
Rosenblum, D., Joshi, N., Tao, W., Karp, J. M., & Peer, D. (2018) · Nature Communications · doi:10.1038/s41467-018-03705-y · Cited by 2,220
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
Zhou, Z., Song, J., Nie, L., & Chen, X. (2016) · Chemical Society Reviews · doi:10.1039/c6cs00271d · Cited by 2,098
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
Ethirajan, M., Chen, Y., Joshi, P., & Pandey, R. K. (2011) · Chem. Soc. Rev. · doi:10.1039/b915149b · Cited by 2,034
Beyond oxidative stress: an immunologist's guide to reactive oxygen species
Nathan, C., & Cunningham-Bussel, A. (2013) · Nature Reviews Immunology · doi:10.1038/nri3423 · Cited by 1,619
Tumor-selective catalytic nanomedicine by nanocatalyst delivery
Huo, M., Wang, L., Chen, Y., & Shi, J. (2017) · Nature Communications · doi:10.1038/s41467-017-00424-8 · Cited by 1,322
Block copolymer micelles in nanomedicine applications
Cabral, H., Miyata, K., Osada, K., & Kataoka, K. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00199 · Cited by 1,309
Self-citationInnovative Strategies for Hypoxic‐Tumor Photodynamic Therapy
Li, X., Kwon, N., Guo, T., Liu, Z., & Yoon, J. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201805138 · Cited by 1,175
Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer?
Nakamura, Y., Mochida, A., Choyke, P. L., & Kobayashi, H. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00437 · Cited by 1,101
Cancer cell–selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules
Mitsunaga, M., Ogawa, M., Kosaka, N., Rosenblum, L. T., Choyke, P. L., & Kobayashi, H. (2011) · Nature Medicine · doi:10.1038/nm.2554 · Cited by 1,057
Nitric oxide release: Part II. Therapeutic applications
Carpenter, A. W., & Schoenfisch, M. H. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15273h · Cited by 964
Qian, X., Zheng, Y., & Chen, Y. (2016) · Advanced Materials · doi:10.1002/adma.201602012 · Cited by 882
Benjaminsen, R. V., Mattebjerg, M. A., Henriksen, J. R., Moghimi, S. M., & Andresen, T. L. (2013) · Molecular Therapy · doi:10.1038/mt.2012.185 · Cited by 735
Dual Redox Responsive Assemblies Formed from Diselenide Block Copolymers
Ma, N., Li, Y., Xu, H., Wang, Z., & Zhang, X. (2010) · Journal of the American Chemical Society · doi:10.1021/ja908124g · Cited by 720
Noninvasive imaging of tumor redox status and its modification by tissue glutathione levels.
Kuppusamy, P., Li, H., Ilangovan, G., Cardounel, A. J., Zweier, J. L., Yamada, K., Krishna, M. C., & Mitchell, J. B. (2002) · PubMed · Cited by 685
Reactive‐Oxygen‐Species‐Responsive Drug Delivery Systems: Promises and Challenges
Saravanakumar, G., Kim, J., & Kim, W. J. (2017) · Advanced Science · doi:10.1002/advs.201600124 · Cited by 675
Selenium-Containing Polymers: Promising Biomaterials for Controlled Release and Enzyme Mimics
Xu, H., Cao, W., & Zhang, X. (2013) · Accounts of Chemical Research · doi:10.1021/ar4000339 · Cited by 586
Hou, Z., Zhang, Y., Deng, K., Chen, Y., Li, X., Deng, X., Cheng, Z., Lian, H., Li, C., & Lin, J. (2015) · ACS Nano · doi:10.1021/nn506107c · Cited by 570
Kemp, J. A., Shim, M. S., Heo, C. Y., & Kwon, Y. J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.019 · Cited by 506
Regulation of apoptosis-associated lysosomal membrane permeabilization
Johansson, A.-C., Appelqvist, H., Nilsson, C., Kågedal, K., Roberg, K., & Öllinger, K. (2010) · Apoptosis · doi:10.1007/s10495-009-0452-5 · Cited by 463
Photochemical internalization: a novel technology for delivery of macromolecules into cytosol.
Berg, K., Selbo, P. K., Prasmickaite, L., Tjelle, T. E., Sandvig, K., Moan, J. E., Gaudernack, G., Fodstad, Ø., Kjølsrud, S., Anholt, H., et al. (1999) · PubMed · Cited by 423
Nitric Oxide Donor-Based Cancer Therapy: Advances and Prospects
Huang, Z., Fu, J., & Zhang, Y. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01672 · Cited by 406
Long-Circulating Au-TiO2Nanocomposite as a Sonosensitizer for ROS-Mediated Eradication of Cancer
Deepagan, V. G., You, D. G., Um, W., Ko, H., Kwon, S., Choi, K. Y., Yi, G.-R., Lee, J. Y., Lee, D. S., Kim, K., et al. (2016) · Nano Letters · doi:10.1021/acs.nanolett.6b02547 · Cited by 402
Self-citationLight-induced gene transfer from packaged DNA enveloped in a dendrimeric photosensitizer
Nishiyama, N., Iriyama, A., Jang, W.-D., Miyata, K., Itaka, K., Inoue, Y., Takahashi, H., Yanagi, Y., Tamaki, Y., Koyama, H., et al. (2005) · Nature Materials · doi:10.1038/nmat1524 · Cited by 340
Self-citationROS-generating TiO2 nanoparticles for non-invasive sonodynamic therapy of cancer
You, D. G., Deepagan, V. G., Um, W., Jeon, S., Son, S., Chang, H., Yoon, H. I., Cho, Y. W., Swierczewska, M., Lee, S., et al. (2016) · Scientific Reports · doi:10.1038/srep23200 · Cited by 327
Self-citationTumor-targeting hyaluronic acid nanoparticles for photodynamic imaging and therapy
Yoon, H. Y., Koo, H., Choi, K. Y., Lee, S. J., Kim, K., Kwon, I. C., Leary, J. F., Park, K., Yuk, S. H., Park, J. H., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.02.016 · Cited by 284
Self-citationRiganti, C., Miraglia, E., Viarisio, D., Costamagna, C., Pescarmona, G., Ghigo, D., & Bosia, A. (2005) · Cancer Research · doi:10.1158/0008-5472.516.65.2 · Cited by 271
The promise of sonodynamic therapy
Trendowski, M. (2014) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9461-5 · Cited by 228
Zhai, S., Hu, X., Hu, Y., Wu, B., & Xing, D. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.01.002 · Cited by 228
Li, J., Dirisala, A., Ge, Z., Wang, Y., Yin, W., Ke, W., Toh, K., Xie, J., Matsumoto, Y., Anraku, Y., et al. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201706964 · Cited by 219
Self-citationSato, K., Sato, N., Xu, B., Nakamura, Y., Nagaya, T., Choyke, P. L., Hasegawa, Y., & Kobayashi, H. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6843 · Cited by 213
The Promise and Perils of Antioxidants for Cancer Patients
Chandel, N. S., & Tuveson, D. A. (2014) · New England Journal of Medicine · doi:10.1056/nejmcibr1405701 · Cited by 207
Enhanced Phototherapy by Nanoparticle-Enzyme via Generation and Photolysis of Hydrogen Peroxide
Chang, K., Liu, Z., Fang, X., Chen, H., Men, X., Yuan, Y., Sun, K., Zhang, X., Yuan, Z., & Wu, C. (2017) · Nano Letters · doi:10.1021/acs.nanolett.7b01382 · Cited by 204
Pei, P., Sun, C., Tao, W., Li, J., Yang, X., & Wang, J. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.10.010 · Cited by 204
Nomoto, T., Fukushima, S., Kumagai, M., Machitani, K., Arnida, Matsumoto, Y., Oba, M., Miyata, K., Osada, K., Nishiyama, N., et al. (2014) · Nature Communications · doi:10.1038/ncomms4545 · Cited by 195
Self-citationIn situ diselenide-crosslinked polymeric micelles for ROS-mediated anticancer drug delivery
Deepagan, V. G., Kwon, S., You, D. G., Nguyen, V. Q., Um, W., Ko, H., Lee, H., Jo, D.-G., Kang, Y. M., & Park, J. H. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.06.044 · Cited by 194
Self-citationEnhanced delivery of macromolecular antitumor drugs to tumors by nitroglycerin application
Seki, T., Fang, J., & Maeda, H. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01323.x · Cited by 179
Ioannidis, J. P. A., Kim, B. Y. S., & Trounson, A. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0314-y · Cited by 175
Wang, Y., Huang, X., Tang, Y., Zou, J., Wang, P., Zhang, Y., Si, W., Huang, W., & Dong, X. (2018) · Chemical Science · doi:10.1039/c8sc03386b · Cited by 131
Theranostic nanosystems for targeted cancer therapy
Kang, H., Hu, S., Cho, M. H., Hong, S. H., Choi, Y., & Choi, H. S. (2018) · Nano Today · doi:10.1016/j.nantod.2018.11.001 · Cited by 118
Ramasamy, T., Ruttala, H. B., Sundaramoorthy, P., Poudel, B. K., Youn, Y. S., Ku, S., Choi, H., Yong, C. S., & Kim, J. O. (2018) · NPG Asia Materials · doi:10.1038/s41427-018-0034-5 · Cited by 111
Yen, H., Cabral, H., Mi, P., Toh, K., Matsumoto, Y., Liu, X., Koori, H., Kim, A., Miyazaki, K., Miura, Y., et al. (2014) · ACS Nano · doi:10.1021/nn504836s · Cited by 108
Self-citationMaterials Chemistry of Nanoultrasonic Biomedicine
Tang, H., Zheng, Y., & Chen, Y. (2016) · Advanced Materials · doi:10.1002/adma.201604105 · Cited by 108
Han, H. S., Choi, K. Y., Lee, H., Lee, M., An, J. Y., Shin, S., Kwon, S., Lee, D. S., & Park, J. H. (2016) · ACS Nano · doi:10.1021/acsnano.6b05113 · Cited by 107
Self-citationMukai, H., Kogawa, T., Matsubara, N., Naito, Y., Sasaki, M., & Hosono, A. (2017) · Investigational New Drugs · doi:10.1007/s10637-016-0422-z · Cited by 90
Intracellularly Activatable Nanovasodilators To Enhance Passive Cancer Targeting Regime
Deepagan, V. G., Ko, H., Kwon, S., Rao, N. V., Kim, S. K., Um, W., Lee, S., Min, J., Lee, J., Choi, K. Y., et al. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b00495 · Cited by 83
Self-citationA switchable NO-releasing nanomedicine for enhanced cancer therapy and inhibition of metastasis
Xu, Y., Ren, H., Liu, J., Wang, Y., Meng, Z., He, Z., Miao, W., Chen, G., & Li, X. (2019) · Nanoscale · doi:10.1039/c9nr00732f · Cited by 69
Redox Potential and ROS-Mediated Nanomedicines for Improving Cancer Therapy
Glass, S., Gonzalez‐Fajardo, L., Beringhs, A. O., & Lü, X. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7370 · Cited by 49
Maeda, M., Muragaki, Y., Okamoto, J., Yoshizawa, S., Abe, N., Nakamoto, H., Ishii, H., Kawabata, K., Umemura, S., Nishiyama, N., et al. (2017) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2017.06.003 · Cited by 36
Self-citation
Cited by
Polymeric Nanoparticles for Drug Delivery
Beach, M. A., Nayanathara, U., Gao, Y., Zhang, C., Xiong, Y., Wang, Y., & Such, G. K. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00705 · Cited by 1,155
Park, J., Choi, Y., Chang, H., Um, W., Ryu, J. H., & Kwon, I. C. (2019) · Theranostics · doi:10.7150/thno.37198 · Cited by 382
Self-citationWan, X., Song, L., Pan, W., Zhong, H., Li, N., & Tang, B. (2020) · ACS Nano · doi:10.1021/acsnano.9b07789 · Cited by 305
Strategies for enhancing cancer chemodynamic therapy performance
Jana, D., & Zhao, Y. (2022) · Exploration · doi:10.1002/exp.20210238 · Cited by 284
Li, J., & Kataoka, K. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.0c09029 · Cited by 281
Self-citation
Metadata
- Authors
- Kwon, S., Ko, H., You, D. G., Kataoka, K., & Park, J. H.
- Venue
- Accounts of Chemical Research
- Publisher
- American Chemical Society (ACS)
- Published
- 2019-06-26
- Volume
- 52
- Issue
- 7
- Pages
- 1771-1782
- ISSN
- 0001-4842 (ISSN-L)
- 1520-4898
- OpenAlex
- W2955296596
- Cited by
- 370
- References
- 55
- FWCI
- 15.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.